<DOC>
	<DOCNO>NCT01423838</DOCNO>
	<brief_summary>Null hypothesis trial difference solifenacin oxybutynin respect efficacy , side effect , patient satisfaction quality life measure patient overactive bladder .</brief_summary>
	<brief_title>Comparison Solifenacin Oxybutynin Treatment Overactive Bladder</brief_title>
	<detailed_description>In two-month follow-up study , patient overactive bladder randomly assign two group ( solifenacin oxybutynin usual dos ) assess respect baseline characteristic complaint treatment . After initiation treatment first second month follow-up visit patient reassess respect compliance , satisfaction , degree improvement , reason dropout , number severity side effect .</detailed_description>
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>Women 1870 year age , diagnose overactive bladder ( presence least two follow three main criterion : urgency , urge incontinence , frequency nocturia ) Presence stress urinary incontinence , patient still use drug overactive bladder , pregnant woman , woman postpartum period ( woman lactation ) , patient close angle glaucoma , patient chronic constipation , allergy ingredient drug , patient contraindicate condition list printed instruction drug .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Overactive bladder</keyword>
	<keyword>Solifenacin</keyword>
	<keyword>Oxybutynin</keyword>
</DOC>